Connecticut venture funding deals in the third quarter of this year included:

  • Farmington’s Bioarray Genetics, which is developing a diagnostic test to detect breast cancer ($5.2 million);
  • Manchester’s Woven Orthopedic Technologies, which makes gripping sleeves for orthopedic bone screws ($4.2 million); and
  • West Hartford’s ReadyDock, which makes disinfecting stations for cell phones in healthcare and other settings ($1.9 million).

The largest Connecticut deal was $50.5 million raised by New Haven biotech Trevi Therapeutics, which is developing a treatment for the skin condition pruritis.